本立科技 (301065)

ZHEJIANG BENLI TECHNOLOGY CO,LTD.

ASZ

K-Line Chart

No K-line data available

Company NameZhejiang Benli Technology Co., Ltd.
Listing Date2021-09-14
Issue Price42.5RMB
Registered Capital1060210k RMB
Legal RepresentativeWu Zhengjie
Registered AddressNo. 15, Donghai Sixth Avenue, Toumen Port New District, Linhai, Zhejiang Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of pharmaceutical intermediates, pesticide intermediates, and new material intermediates.
Company ProfileZhejiang Benli Technology Co., Ltd. was established on May 13, 2011. Its registered address is No. 15, Donghai Sixth Avenue, Toumen Port New District, Linhai City, Zhejiang Province. The legal representative is Wu Zhengjie. The business scope includes: manufacturing of N,N-dimethylaminoethyl acrylate; research and development of chemical products; wholesale and retail of chemical products; import and export of goods and technology. Annual production capacity: 7,350 tons of 36% hydrochloric acid. Annual by-products: 30,616 tons of 25% aluminum chloride solution. Annual recovery: 10,619 tons of ethanol, 24,723 tons of xylene, 3,648 tons of tri-n-propylamine (operated with valid licenses). (Projects subject to approval by law can only be carried out after approval by relevant departments.) Zhejiang Benli Technology Co., Ltd. has invested in 2 companies.

Stock Details

1. Key Indicators

  • Total Shares(W): 10602.00
  • Circulating A-Shares(W): 8628.75
  • Earnings Per Share(RMB): 0.5400
  • Net Assets Per Share(RMB): 12.6613
  • Operating Revenue(W RMB): 48122.51
  • Total Profit(W RMB): 6453.31
  • Net Profit Attributable to Parent(W RMB): 5578.15
  • Net Profit Growth Rate(%): 10.67
  • Weighted Return on Equity(%): 4.2000
  • Operating Cash Flow Per Share(RMB): 0.9720
  • Undistributed Profit Per Share(RMB): 4.7103
  • Capital Reserve Per Share(RMB): 6.9737

2. Main Business

The main business covers:

  • Research, production, and sales of pharmaceutical intermediates
  • Research, production, and sales of pesticide intermediates
  • Research, production, and sales of new material intermediates

3. Company Basic Information

  • Company Name: Zhejiang Benli Technology Co., Ltd.
  • Listing Date: 2021-09-14
  • Industry: Medicine & Healthcare - Chemical Pharmaceuticals (Tongdaxin Research Industry) / Chemical Raw Material and Chemical Products Manufacturing (CSRC Industry)
  • Address: No. 15, Donghai Sixth Avenue, Toumen Port New District, Linhai City, Zhejiang Province, China
  • Website: www.benlitech.com
  • Company Profile:On October 12, 2014, Benli Co., Ltd. held a shareholders' meeting and resolved to convert the company into a joint-stock company as of December 31, 2014. According to the audit report issued by the issuer's accountant, the net asset value of Benli Co., Ltd. as of December 31, 2014 was RMB 39,595,930.36. According to the asset appraisal report issued by Kunyuan Appraisal, the assessed net asset value as of December 31, 2014 was RMB 112,472,367.25. On June 26, 2015, Benli Technology held its founding meeting and first shareholders' meeting, agreeing that all promoters would convert the audited net assets of Benli Co., Ltd. as of December 31, 2014, amounting to RMB 39,595,930.36, into 35,000,000 shares at a ratio of 1.1313123:1, with a par value of RMB 1 per share. The remaining net assets of RMB 4,595,930.36 were recorded as capital reserve. On June 26, 2015, the issuer's accountant verified the conversion and issued a capital verification report, confirming that the company had received the registered capital of RMB 35 million from all shareholders as of June 26, 2015. On July 3, 2015, the company completed the industrial and commercial change registration. Unified Social Credit Code: 913310005753258189.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Taizhou Shaosi Investment Partnership (Limited Partnership) General Legal Person 787.50 9.13
2 Noah Multi-Strategy Hybrid Securities Investment Fund Class A Fund 70.00 0.81

5. Concept Sectors

  • Margin Trading & Securities Lending
  • Micro-Cap Stocks
  • High-Performance Stocks
  • Below IPO Price
  • Planned Share Reduction
  • Micro-Cap Selection

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information